Whether via new standards adoption or the digital transformation of regulatory processes, data-based ambitions have featured heavily on the pharma agenda in recent years. But it could be knowledge-based graphs and their ability to draw advanced insights from complex data correlations that yield the real benefits.
Read more: https://www.pmlive.com/pme#/reader/49230/219584
Keywords: Dr. Alexander Jarasch Knowledge Graph Life Sciences Thought Leadership